The design of airplane wings and storing organs for transplant could both become safer and more effective, thanks to a synthetic antifreeze which prevents the growth of ice crystals, developed by researchers at the University of Warwick.
Scientists at the University of Oxford have developed a new method to 3-D-print laboratory- grown cells to form living structures. The approach could revolutionise regenerative medicine, enabling the production of complex tissues and cartilage that would potentially support, repair or augment diseased and damaged areas of the body.
A group of U of T Engineering researchers has demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).
The team from Instituto de Medicina Molecular Lisboa, led by Luis Graça, analyzed blood samples from Sjögren syndrome patients, an autoimmune disease that affects the mucous membranes and moisture-secreting glands of the eyes and mouth, and found that these patients have a significant increase in a specific type of immune cells called T follicular regulatory cells (Tfr).
It's a cancer of the plasma cells, which normally make an array of antibodies that protect us from infection.
A routinely used hospital tool can predict which liver transplant recipients are more likely to do poorly after surgery, according to a study led by Cedars-Sinai. The findings could help doctors identify which patients should receive physical therapy or other targeted interventions to improve their recovery.
A short exposure to an alternating magnetic field might someday replace multiple surgeries and weeks of IV antibiotics as treatment for stubborn infections on artificial joints, new research suggests.
A phase II clinical trial shows that patients who received a hematopoietic stem cell transplant and developed a viral infection could be helped by receiving immune cells specialized in eliminating that particular virus.
Researchers have developed a device that can switch cell function to rescue failing body functions with a single touch. The technology, known as Tissue Nanotransfection (TNT), injects genetic code into skin cells, turning those skin cells into other types of cells required for treating diseased conditions.
An experimental treatment derived from a potentially deadly microorganism may provide lifesaving help for kidney transplant patients, according to an international study led by investigators at Cedars-Sinai.